Is Bortezomib a Rare Cause of Acute Pancreatitis?

  • Tevfik Solakoglu Department of Gastroenterology, Ankara Ataturk Education and Research Hospital. Ankara, Turkey
  • Mustafa Akar Department of Gastroenterology, Ankara Ataturk Education and Research Hospital. Ankara, Turkey
  • Tugba Aktan Kosker Department of Internal Medicine, Ankara Ataturk Education and Research Hospital. Ankara, Turkey
  • Semnur Buyukasik Department of Gastroenterology, Ankara Ataturk Education and Research Hospital. Ankara, Turkey
  • Osman Ersoy Department of Gastroenterology, Yildirim Beyazit University, Faculty of Medicine. Ankara, Turkey
DOI: https://doi.org/10.6092/1590-8577/1927
Keywords: bortezomib, Multiple Myeloma, Pancreatitis, Acute Necrotizing

Abstract

No abstract available.

Image: Proteasome inhibitor bortezomib bound to an assembled yeast proteasome core (PDB ID 2F16). (From Wikimedia Commons).

Downloads

Download data is not yet available.

Author Biographies

Tevfik Solakoglu, Department of Gastroenterology, Ankara Ataturk Education and Research Hospital. Ankara, Turkey
Department of Gastroenterology
Mustafa Akar, Department of Gastroenterology, Ankara Ataturk Education and Research Hospital. Ankara, Turkey
Department of Gastroenterology
Tugba Aktan Kosker, Department of Internal Medicine, Ankara Ataturk Education and Research Hospital. Ankara, Turkey
Department of Internal Medicine
Semnur Buyukasik, Department of Gastroenterology, Ankara Ataturk Education and Research Hospital. Ankara, Turkey
Department of Gastroenterology
Osman Ersoy, Department of Gastroenterology, Yildirim Beyazit University, Faculty of Medicine. Ankara, Turkey
Department of Gastroenterology

References

Elouni B, Ben Salem C, Zamy M, Sakhri J, Bouraoui K, Biour M. Bortezomib-induced acute pancreatitis (Letter). JOP. J pancreas (Online) 2010; 11:275-6.

Kane RC, Bross PF, Farrell AT, Pazdur R. Velcade: U.S. FDA approval for the treatment of multiple myeloma progressing on prior therapy. Oncologist. 2003;8:508-13.

Nitsche CJ, Jamieson N, Lerch MM, Mayerle JV. Drug induced pancreatitis. Best Pract Res Clin Gastroenterol. 2010;24:143-55.

Mihaila RG. A possible rare complication of bortezomib treatment: acute pancreatitis. Acta Medica Transilvanica 2013; 2:269-71.

Proteasome inhibitor bortezomib bound to an assembled yeast proteasome core (PDB ID 2F16).
Published
2013-11-10
How to Cite
SolakogluT., AkarM., Aktan KoskerT., BuyukasikS., & ErsoyO. (2013). Is Bortezomib a Rare Cause of Acute Pancreatitis?. JOP. Journal of the Pancreas, 14(6), 682-683. https://doi.org/10.6092/1590-8577/1927
Issue
Vol 14 No 6 (2013): November - p. 603-693
Section
LETTERS

Copyright (c) 2014 Tevfik Solakoglu, Mustafa Akar, Tugba Aktan Kosker, Semnur Buyukasik, Osman Ersoy

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

As a member of Publisher International Linking Association, PILA, iMedPub Group’s JOP follows the Creative Commons Attribution License and Scholars Open Access publishing policies. Journal of the Pancreas is the Council Contributor Member of Council of Science Editors (CSE) and following the CSE slogan Education, Ethics, and Evidence for Editors.